Clinical Research Directory
Browse clinical research sites, groups, and studies.
Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy
Sponsor: Fujian Medical University Union Hospital
Summary
The aim of this study is to explore the impact of internal mammary nodal irradiation on disease-free survival in high-risk breast cancer patients (ypN+or supra/subclavicular lymph node positive) after neoadjuvant chemotherapy.
Official title: Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy: a Phase III Randomized, Controlled Clinical Trial
Key Details
Gender
FEMALE
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
722
Start Date
2024-07-15
Completion Date
2032-07-15
Last Updated
2024-09-19
Healthy Volunteers
Yes
Conditions
Interventions
internal mammary nodal irradiation
chest wall/whole breast and supraclavicular +-axillary plus internal mammary nodal irradiation (50 Gy in 25 fractions or 40Gy in 15 fractions).
No internal mammary node irradiation
chest wall/whole breast and supraclavicular +-axillary irradiation (50 Gy in 25 fractions or 40Gy in 15 fractions).
Locations (1)
Fujian Medical University Union Hospital
Fuzhou, Fujian, China